Therapeutic Areas

Product Development Focus

Further to the cultivation, we are already in collaboration with an R&D center to develop innovative single dose products forms.

We are targeting formulation and administration strategies optimizing cannabinoid bioavailability and onset time. Our strategy allows for the expansion of physiological applications based on improved performance as well as cost-effective product diversification for a given API. Development activities have focused on oromucosal tissues and deliveries along with nanotechnology and molecular encapsulation.​